These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 846521)

  • 1. Enzyme replacement with red cells.
    N Engl J Med; 1977 Apr; 296(16):942-3. PubMed ID: 846521
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.
    Rubinstein A; Hirschhorn R; Sicklick M; Murphy RA
    N Engl J Med; 1979 Feb; 300(8):387-92. PubMed ID: 310515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency.
    Schmalstieg FC; Mills GC; Nelson JA; May LT; Goldman AS; Goldblum RM
    J Pediatr; 1978 Oct; 93(4):597-603. PubMed ID: 308999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency.
    Polmar SH; Stern RC; Schwartz AL; Wetzler EM; Chase PA; Hirschhorn R
    N Engl J Med; 1976 Dec; 295(24):1337-43. PubMed ID: 980079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine and deoxyadenosine metabolism in the erythrocytes of a patient with adenosine deaminase deficiency.
    Sahota A; Simmonds HA; Potter CF; Watson JG; Hugh-Jones K; Perrett D
    Adv Exp Med Biol; 1980; 122A():397-401. PubMed ID: 6999851
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of enzyme replacement on red cell adenine deoxyribonucleotides in adenosine deaminase-deficient erythrocytes of the opossum, Didelphis virginiana.
    Bethlenfalvay NC; Lima JE; Banks RE
    Comp Biochem Physiol B; 1993 Nov; 106(3):635-9. PubMed ID: 8281757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
    Hershfield MS; Buckley RH; Greenberg ML; Melton AL; Schiff R; Hatem C; Kurtzberg J; Markert ML; Kobayashi RH; Kobayashi AL
    N Engl J Med; 1987 Mar; 316(10):589-96. PubMed ID: 3807953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy.
    Yulish BS; Stern RC; Polmar SH
    Am J Dis Child; 1980 Jan; 134(1):61-3. PubMed ID: 7350788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adenosine deaminase replacement therapy on a child of adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Tsuchiya S; Arai N; Kudo M; Konno T; Tada K; Yokoyama S
    Tohoku J Exp Med; 1979 Jul; 128(3):251-8. PubMed ID: 494247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme loading of erythrocytes.
    Ihler GM; Glew RH; Schnure FW
    Proc Natl Acad Sci U S A; 1973 Sep; 70(9):2663-6. PubMed ID: 4354859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomedical applications of enzymes and their polyethylene glycol adducts.
    Fortier G
    Biotechnol Genet Eng Rev; 1994; 12():329-56. PubMed ID: 7727031
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy.
    Ziegler JB; Lee CH; Van der Weyden MB; Bagnara AS; Beveridge J
    Arch Dis Child; 1980 Jun; 55(6):452-7. PubMed ID: 7436484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies with human carrier erythrocytes loaded with polyethylene glycol-conjugated and native adenosine deaminase.
    Bax BE; Bain MD; Fairbanks LD; Webster AD; Chalmers RA
    Br J Haematol; 2000 Jun; 109(3):549-54. PubMed ID: 10886203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What opportunities are afforded by enzyme replacement therapy].
    Huppertz HI
    Z Rheumatol; 2006 Feb; 65(1):44-5. PubMed ID: 16804994
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.
    Hutton JJ; Wiginton DA; Coleman MS; Fuller SA; Limouze S; Lampkin BC
    J Clin Invest; 1981 Aug; 68(2):413-21. PubMed ID: 7263861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
    Bax BE; Bain MD; Fairbanks LD; Webster AD; Ind PW; Hershfield MS; Chalmers RA
    Eur J Haematol; 2007 Oct; 79(4):338-48. PubMed ID: 17680812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease.
    Dyminski JW; Daoud A; Lampkin BC; Limouze S; Donofrio J; Coleman MS; Hutton JJ
    Clin Immunol Immunopathol; 1979 Nov; 14(3):307-26. PubMed ID: 498598
    [No Abstract]   [Full Text] [Related]  

  • 19. The entrapment of polyethylene glycol-bound adenosine deaminase (Pegademase) in human carrier erythrocytes.
    Bax BE; Fairbanks LD; Bain MD; Simmonds HA; Chalmers RA
    Biochem Soc Trans; 1996 Aug; 24(3):442S. PubMed ID: 8878986
    [No Abstract]   [Full Text] [Related]  

  • 20. Catabolism of adenine nucleotides in adenosine deaminase deficient erythrocytes.
    Mills GC; Goldblum RM; Schmalstieg FC
    Life Sci; 1981 Oct; 29(17):1811-20. PubMed ID: 7300574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.